Reuters logo
BRIEF-Aerie Pharmaceuticals Q3 loss per share $0.89
November 8, 2017 / 9:10 PM / a month ago

BRIEF-Aerie Pharmaceuticals Q3 loss per share $0.89

Nov 8 (Reuters) - Aerie Pharmaceuticals Inc

* Aerie Pharmaceuticals reports third quarter 2017 financial results and provides business update

* Q3 adjusted loss per share $0.71

* Q3 earnings per share view $-0.63 -- Thomson Reuters I/B/E/S

* Q3 gaap loss per share $0.89

* Aerie Pharmaceuticals Inc - ‍as of september 30, 2017, Aerie had $282.2 million in cash, cash equivalents and investments​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below